Centrum Wsparcia Badań Klinicznych PUM

What Centrum Wsparcia Badań Klinicznych PUM does

Centrum Wsparcia Badań Klinicznych PUM (CWBK PUM) is an organizational unit of Pomorski Uniwersytet Medyczny w Szczecinie (Pomeranian Medical University in Szczecin, Poland), established in 2020 to coordinate clinical research activity across the university. The unit's core function is to provide regulatory, infrastructural, and coordination support for both commercial and non-commercial clinical trials, serving three audience groups explicitly named in its outreach: academic researchers affiliated with PUM, external sponsors (industry and non-commercial), and patients participating in clinical research. Operationally, the center draws on the two affiliated University Clinical Hospitals (Uniwersytecki Szpital Kliniczny nr 1 and nr 2) as the trial-site backbone.

The center's underlying technology stack is conventional academic-infrastructure rather than purpose-built clinical-trial software: the parent university operates a Wirtualny Dziekanat student administration system, a Moodle-based LMS, an online recruitment platform, and the Polska Platforma Medyczna (Polish Medical Platform) for research knowledge management. No proprietary eClinical, EDC, or AI-enabled trial tooling is disclosed. The center's active project portfolio — EPICARD-HD (an epigenetic cardiovascular-risk calculator for hemodialysis patients), NANOVA (anti-angiogenic nanocarrier preclinical development), HIV NGS sequencing implementation, and CWBK 2 (capacity expansion) — is funded primarily through the Polish Medical Research Agency (Agencja Badań Medycznych) and the National Recovery Plan (KPO).

The business model is that of a publicly funded university service unit rather than a commercial contract research organization. CWBK does not publicly disclose service pricing; trial-related revenue, where it exists, is treated as institutional income of the parent university, alongside government subsidies, tuition, and research grants. Headcount is small (8 identified employees), leadership is anchored by Piotr Czupryński, and customer relationships are B2B/B2G in nature — sponsors and academic investigators — with patients as research participants rather than fee-paying customers. Go-to-market is passive and institutional, relying on the PUM corporate website, social channels, BIP public-procurement bulletin, and EU/national grant announcements rather than outbound sales.

Name

Centrum Wsparcia Badań Klinicznych PUM

Legal name

Pomorski Uniwersytet Medyczny w Szczecinie

Website

https://pum.edu.pl

Company type

Private

Founded year

1948

Operating status

Operating

Headcount range

1–10 employees

Short description

Centrum Wsparcia Badań Klinicznych PUM coordinates commercial and non-commercial clinical trials at Pomeranian Medical University in Szczecin, Poland, serving academic researchers, trial sponsors, and patients via the university's two university clinical hospitals.

Ownership category

akta.pro rank

Product category

Clinical Research Services

NAICS

Research and Development in the Physical, Engineering, and Life Sciences (54171), Scientific Research and Development Services (5417)

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro industry

PRIMARYHLAGACAG

Clinical Trial Monitoring Support (On-site/Remote)

Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Clinical Trial Services & Site Management (SMO)

SECONDARYEDAHAAAC

Public Research Universities with Academic Medical Centers (AMCs)

Education/Higher Education (Colleges & Universities)/Public Research Universities

SECONDARYHLAGAKAI

Clinical Quality Assurance (GCP QA, TMF/QMS oversight)

Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Regulatory Affairs, Quality & Compliance Services (GxP)

Keywords

• Clinical trial support
• Clinical research services
• Academic medical research
• Clinical study coordination
• Medical research infrastructure

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure

Distribution channels1 record

Marketing channels4 records

Core offering

Centrum Wsparcia Badań Klinicznych PUM is a dedicated unit within Pomeranian Medical University that supports researchers, sponsors, and patients in conducting commercial and non-commercial clinical trials. The center provides regulatory guidance, infrastructure access through affiliated university clinical hospitals, and coordination among investigators, sponsors, and participants. It enables structured clinical research activities including funded projects such as EPICARD-HD, NANOVA, HIV NGS, and CWBK 2 capacity expansion.

Product overview

Centrum Wsparcia Badań Klinicznych PUM operates as part of the Pomorski Uniwersytet Medyczny w Szczecinie (Pomeranian Medical University in Szczecin). The university offers a portfolio of educational platforms including Wirtualny Dziekanat for student administration, Moodle PUM LMS for e-learning, and a dedicated Recruitment Platform. Supporting services include the Medical Simulation Center for practical training, the Publishing House for scientific publications, and the Polish Medical Platform for research knowledge management. The Clinical Research Support Center itself facilitates commercial and non-commercial clinical trials for researchers, sponsors, and patients.

Differentiator

Problem solved

Functional benefit

Products and services

• Clinical Research Support Services

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

One partnership is on record.

• Agencja Badań Medycznych (Medical Research Agency)coreStrategic or Co-development PartnerThe center collaborates with the Medical Research Agency on multiple funded projects including EPICARD-HD (epigenetic calculator for cardiovascular risk), NANOVA (innovative nanocarrier development), HIV NGS sequencing project, and CWBK 2 (capacity expansion). These projects represent the core research portfolio supported through national funding mechanisms.

Recent moves5 records

Expansion highlights5 records

Broad incumbents

• Eurofins Scientific: Eurofins is a global life-sciences testing group with clinical-research-support services and Poland operations; comparable to CWBK in providing clinical and biological research/testing services, but at vastly broader scale.
• Medpace Holdings: Medpace is a global CRO providing clinical trial management and site support services, including European operations; comparable in clinical research services category to CWBK's site-support role but at multi-region scale.
• IQVIA: IQVIA is a global CRO and clinical research services provider operating across Poland and CEE; offers end-to-end clinical trial support comparable in category to CWBK's site-support services but at global scale with commercial trial focus.
• Parexel International: Parexel is a global CRO providing clinical trial management and site support services with presence in Poland; comparable to CWBK in clinical-trial service category but with global infrastructure and commercial-trial focus.
• ICON plc: ICON is a global CRO providing clinical trial management and site support services across Europe, including Poland; comparable in clinical research service category but with vastly greater scale and commercial-trial focus than CWBK.
• Charles River Laboratories: Charles River Laboratories is a global CRO providing preclinical and clinical research services; comparable in the broader clinical research support category but operating at enterprise scale across multiple geographies.
• Labcorp (Clinical Development & Commercialization Services): Labcorp operates global clinical laboratory and clinical development services with operations in Europe; comparable in category to CWBK for clinical-research-support and laboratory services supporting trials.

Regional players

• Synevo (Medicover group): Synevo operates one of the largest clinical laboratory networks in Central and Eastern Europe, including Poland; comparable to CWBK in supporting clinical research through diagnostic testing infrastructure within the Polish market.
• Diagnostyka S.A. Diagnostyka is the largest Polish clinical diagnostic laboratory network; operates as a Poland-centric clinical-research-support infrastructure provider in a similar vein to CWBK's local diagnostic/trial-support role.

Emerging players

• Agencja Badań Medycznych (Medical Research Agency of Poland): The Polish Medical Research Agency funds and oversees academic clinical research centers including CWBK; it operates within the same Polish clinical-research ecosystem, allocating grants and shaping the country's clinical-research infrastructure strategy.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights5 records

Customer concentration

• Xx.com/pumszczecin
• YouTubeyoutube.com/pomorskiuniwersytetmedycznywszczecinie
• Facebookfacebook.com/pumszczecin
• Instagraminstagram.com/pumszczecin
• LinkedInlinkedin.com/company/centrum-wsparcia-bada%C5%84-klinicznych-pum

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Subsidiaries7 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Centrum Wsparcia Badań Klinicznych PUM